How alcohol affects the progression of Alzheimer’s disease
Inflammasome activation in modulation of Alzheimer’s Disease by alcohol Administrative Supplement
This study looks at how drinking too much alcohol might affect the development and worsening of Alzheimer’s disease, aiming to find ways to help people by understanding the connection between alcohol use and Alzheimer’s symptoms.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10895811 on NIH RePORTER |
What this research studies
This research investigates the impact of excessive alcohol consumption on the development and progression of Alzheimer’s disease (AD). It focuses on understanding how chronic alcohol exposure activates specific immune pathways, particularly the NLRP3 inflammasome, which may worsen neuroinflammation and accelerate AD symptoms. By using mouse models of AD, the study aims to identify critical molecular pathways that could serve as potential therapeutic targets for treatment. Patients may benefit from insights gained about the relationship between alcohol use and AD progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a diagnosis of Alzheimer’s disease who have a history of excessive alcohol use.
Not a fit: Patients who do not have Alzheimer’s disease or those who do not consume alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing Alzheimer’s disease in individuals with a history of heavy alcohol consumption.
How similar studies have performed: Previous research has shown that targeting neuroinflammation can be beneficial in Alzheimer’s disease, suggesting that this approach may yield valuable insights.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Szabo, Gyongyi — Beth Israel Deaconess Medical Center
- Study coordinator: Szabo, Gyongyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.